Clinical Study Quality. On the Roadmap.
Clinical study management is GCP-adjacent. GCP is Phase 3 on the Verixa roadmap (2028+) — a planned module, not a live product today. Verixa Phase 1 covers GMP.
This page describes a roadmap commitment. Express interest to help shape clinical study management as an early founding partner.
What Teams Face Today
Fragmented Trial Data
Clinical quality records scattered across disparate CRO systems, emails, and isolated eTMF platforms.
Protocol Deviations
Significant delays in detecting, reporting, and investigating critical site-level GCP protocol deviations.
TMF Document Quality
Hundreds of hours spent manually verifying Trial Master File (TMF) completeness right before regulatory audits.
Site Performance Gaps
Lack of real-time visibility into underperforming clinical investigator sites and protocol adherence across global trials.
Where Verixa Is Headed
Centralized Clinical Oversight
Planned for the GCP module: one place for clinical quality events, deviations, and sponsor CAPAs.
Deviation Workflows
On the roadmap: triage, escalation, and investigation processes for protocol deviations.
TMF Readiness
A roadmap goal: document-quality checks that help keep the Trial Master File ready for inspection.
Site Quality Visibility
Targeted for the GCP module: dashboards surfacing quality metrics across trial sites.
Study Management
Direction for future clinical study management. These capabilities are not available today and are subject to change.
Protocol Deviation Tracking
Planned: classification, root-cause analysis, and patient-impact assessment, designed to align with ICH E6(R3).
eTMF Integrations
On the roadmap: API integrations with eTMF platforms to sync quality records and inspection files.
Clinical CAPA Management
A roadmap goal: workflows to investigate non-compliance and implement preventive actions at specific sites.
Investigator Scorecards
Targeted for the GCP module: reporting on site-level quality performance and training gaps.
Help Shape Clinical Study Management
Clinical study management is GCP-adjacent and a Phase 3 roadmap commitment (2028+), not a live module. Tell us about your clinical operations to be considered for early design-partner participation.